Medindia

X

Cannabis Companies Trending on Recent News

Thursday, November 3, 2016 Drug News J E 4
Advertisement

NEW YORK, November 3, 2016 /PRNewswire/ --

http://www.Financialbuzz.com - Next week is a crucial time for the legalization of cannabis in either recreational or medical use in nine states across the nation as balloting starts. At the end of 2016, the regulated cannabis sector in the U.S. is anticipated to rise over $7 billion if California says yes, as reported by ArcView Market Research and New Frontier. This analysis is an astounding 26 percent improvement compared to the previous year and compelled mostly by recreational sales. Regulated recreational cannabis sales had surpassed nearly a billion dollars in 2015 compared to $351 million in 2014 the report continued to report.

Singlepoint Inc. (OTC: SING), Terra Tech Corp. (OTC: TRTC), GrowBlox Sciences Inc. (OTC: GBLX), Medicine Man Technologies, Inc. (OTC: MDCL), Cannabis Sativa Inc. (OTC: CBDS)

Many small companies and businesses are preparing for balloting outcomes to turn out positive for medical or recreational use in cannabis. These small and large companies are positioning themselves by keeping the public and their shareholder base abreast with key corporate developments. Companies are vast and in a variety of cannabis sectors of businesses.

One small company that just announced new corporate developments in the cannabis sector is, Singlepoint Inc. (OTC: SING). The company announced that, SingleSeed, a subsidiary focused on providing merchant solutions for the cannabis industry, is awakening from a quiet period to take advantage of increased demand and legislative shifts within the cannabis market.

"This is an ideal time to actively engage the marketplace and ramp up relations with existing clients," states SinglePoint CEO Greg Lambrecht. "Additionally, there are a number of other smaller companies in this space that, as part of our overall rollup initiative, we would seek to acquire."  Politicians on both sides of the aisle are pushing for solutions to the marijuana banking conundrum on state and federal levels.  SinglePoint's Board of Directors is confident that results of next week's election will not derail unified efforts to make way for allowing these companies to be "bankable."  

"Though banks and credit unions will not openly acknowledge whether or not they will open Cannabis operations accounts, more and more are deciding to be vocal about their acceptance, and our processor has extensive relationships in a fast-growing industry that has developed to a point where we are confident to proceed toward ramp-up on SingleSeed operations and initiatives. As we look to further engage the marketplace, we will work with our technology partners to develop apps which help protect the industry with a safe way to transact monies for business owners operating within the confines of state laws and guidelines set forth for banks by federal authorities," adds Lambrecht.

Lambrecht concludes, "The bottom line, shareholders, is that we know this business, we have amassed a customer base in this business and we are prepared to aggressively enter this market with resources and legislation that were previously unavailable to us."

Terra Tech Corp. (OTCQX: TRTC) subsidiary IVXX™, hand selects and harvests the finest-grade cannabis under the safest and most beneficial conditions, free of toxic pesticides, harmful molds and chemical residues. Its products are carefully produced, rigorously tested and certified to the highest standards of potency and purity. Currently, the company's hand selected strains are the I-Hybrid and S-Hybrid. IVXX offers pure concentrates ranging from Shatter, Wax to Oil, which are all produced in its advanced extraction labs, along with custom rolled joints.

GrowBlox Sciences Inc. (OTCQB: GBLX) recently announced the filing of the first of several patent applications for life science inventions by its wholly-owned subsidiary, Growblox Life Sciences, LLC.  The current provisional patent application covers complex-cannabinoid-containing mixtures capable of enhancing dopamine secretion and protect neurons from the mitochondrial-induced free radical damage that occurs during disease progression in the brains of patients with Parkinson's disease, Alzheimer's disease, Lewy Body Dementia, and Huntington's disease, among others.

Medicine Man Technologies, Inc. (OTCQB: MDCL) announced recently that it has added eight new licensing clients in October including five in Pennsylvania, two in Puerto Rico, and one in Florida. The company further noted the addition of two clients in California under its new Cultivation MAX services product bringing the total new clients added in October to ten.

Cannabis Sativa Inc. (OTCQB: CBDS) subsidiary, Ibudtender, is anchoring a Prop 215 event in San Francisco's Cow Palace this Halloween. Ibudtender is currently the technology arm of Hempcon. The company will be featuring its Wild Earth Naturals cannabidiol infused water at the Ibudtender booth. Eventgoers are invited to Ibudtender's booth to check out its latest technology for the cannabis sector.

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

For "The Latest Buzz in Financial News", SIGN UP & Visit: http://www.FinancialBuzz.com

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com    

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and pr marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. Financialbuzz.com has been compensated four thousand dollars for financial news dissemination and pr services directly from singlepoint inc. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information: Media Contact: Danny A, info@financialbuzz.com , +1-877-601-1879 Url: http://www.FinancialBuzz.com

SOURCE FinancialBuzz.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
NRGene and Japan's Kazusa DNA Research Institute F...
S
Gradalis to Take Part in the 22nd Annual BIO Europ...